Improvement in the treatment of diffuse large cell lymphoma (DLCL) over the last 15 years has been one of the notable successes of modern chemotherapy. This paper reports a three year experience (1985–87) of 46 unselected consecutive patients with DLCL in a single teaching hospital. A striking finding was that visceral, extranodal presentations were disproportionately common. The excellent response of stage I patients to chemotherapy alone is emphasised as is the role of immunophenotyping in diagnosis.
|Number of pages||3|
|Journal||Australian and New Zealand Journal of Medicine|
|State||Published - Apr 1989|